BRCA2 and hypoparathyroidism-retardation-dysmorphism syndrome: Additionally, pathogenic/likely pathogenic germline and oncogenic/likely oncogenic somatic mutation calls were made for the BRCA1, BRCA2, and PALB2 genes and were considered indicators of homologous recombination deficiency (HRD).